Hati-Cancer Company
Hati-Cancer is developing new drugs for metastatic cancer targeted therapy. The company was composed of 4 founders: Bruno Azevedo (CEO), Miguel Sousa (CTO), Ricardo Soares (COO), Rodrigo Pires (CCO), who are all Electrical Engineers.
Total Funding:
121642
Founded Date:
2015-01-01
Industry:
Quantum Biology
Last Funding Date:
2021-02-22
Funding Status:
private
Headquarters:
Lisbon,Lisboa,Portugal,Europe
Super Industry:
Quantum Science Applications
Funding Total Value:
100000
Last Funding Total Usd:
121642
Last Funding Total Currency:
EUR
Last Funding Total Value:
100000
Founders:
Andreia Valente,Helena Garcia